title: Targeting low-density lipoprotein and dysmetabolism in type 2 diabetes mellitus.
authors.affiliation: From the University of Miami Miller School of Medicine, FL.
authors.forename: Ronald
authors.initials: R
authors.lastname: Goldberg
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003998:Dicarboxylic Acids / Q000627:therapeutic use*; D005227:Fatty Acids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D003998:Dicarboxylic Acids; D005227:Fatty Acids; C581236:8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
keywords: Editorials; LDL-cholesterol; type 2 diabetes